Search
for
Sort by
Research 151–180 of 1000+
- Baricitinib Demonstrates Rapid Action Within Just 2 Months of Treatment in Severe and Unresponsive Alopecia Areata: A Case Report
- Upadacitinib for the treatment of alopecia areata – A case report
- Tofacitinib citrate alleviates alopecia universalis symptoms in recent case study
- Quoi de neuf en dermatologie pédiatrique ?
- Treatment of moderate-to-severe alopecia areata in pre-adolescent children with baricitinib
- Successful treatment of concomitant alopecia universalis and Crohn’s disease with upadacitinib: A case report
- Upadacitinib for management of recalcitrant alopecia areata: A retrospective case series
- 44096 Efficacy in Subgroups related to Disease Characteristics in Patients with Alopecia Areata from BRAVE-AA1 and BRAVE-AA2
- Ivarmacitinib in atopic dermatitis presenting with prurigo nodularis-like lesions and alopecia areata: a case report
- 0480 Upadacitinib monotherapy for treatment of pyoderma gangrenosum: A case series
- Ivarmacitinib stimulates hair regrowth in severe alopecia areata
- Efficacy and safety of baricitinib in patients with alopecia areata: evidence to date
- Spotlight in Plastic Surgery: October 2022
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study
- 290 Brepocitinib improves cicatricial alopecia and downregulates key T-helper biomarkers
- Adverse events in patients treated with Jak‐inhibitors for alopecia areata: A systematic review
- Public Interest in Janus Kinase (JAK) IInhibitors for Alopecia Areata: A Google Trend Analysis
- Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review
- JAK Inhibitors in African American Patients With Alopecia Areata: A Case Series
- Alopecia Universalis Treated With Tofacitinib: The Role of JAK/STAT Inhibitors in Hair Regrowth
- Treatment Response to JAK Inhibitors in Long-standing Alopecia Areata (≥8 Years): A Real-world Observational Study
- Safety and efficacy of tofacitinib in 97 alopecia areata patients
- The emerging role of Janus kinase inhibitors in the treatment of autoimmune and inflammatory diseases
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- Efficacy of Janus kinase inhibitors in adult patients with alopecia areata
- JAK Inhibitor Therapy in Alopecia Areata with Latent Hepatitis B Virus or Tuberculosis Infection: A Safety Assessment
- JAK Inhibitor Therapy in Alopecia Areata with Latent Hepatitis B Virus or Tuberculosis Infection: A Safety Assessment
- Public Interest in JAK Inhibitors for Alopecia Areata: A Google Trend Analysis (Preprint)
- Janus Kinase (JAK) Inhibitors in Dermatology: An Update and Critical Review
- JAK kinase pathway inhibitor drugs in patients with moderate-to-severe alopecia: a real-world experience